SAR-101099

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSAR-101099
Drug Alias NameSAR 101099SAR101099
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUrotensin II receptor antagonists
TargetsUrotensin II receptor
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksN/A